QNCX (Quince Therapeutics) FFO


QNCX Quince Therapeutics Inc QNCX
21 GF Score
Price $17.48
! 2 Warning Signs
View Full Analysis

What is Quince Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

QNCX
21GF Score
Quince Therapeutics Inc QNCX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quince Therapeutics Business Description

Address 611 Gateway Boulevard, Suite 273, South San Francisco, CA, USA, 94080
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
21GF Score

Get the complete analysis for QNCX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.48
Price